4.6 Editorial Material

Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials

期刊

CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 107, 期 4, 页码 735-737

出版社

WILEY
DOI: 10.1002/cpt.1793

关键词

-

资金

  1. FDA [HHSF223201710186C]
  2. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital
  3. National Heart, Lung, and Blood Institute [R01HL141505]

向作者/读者索取更多资源

Actionable real-world evidence (RWE) requires accurate estimation of causal treatment effects. Calibration of RWE against randomized controlled trials (RCTs) is sometimes done to demonstrate that RWE can support the same causal conclusion as RCTs. Disagreements can occur when studies in each pair asked different questions in different populations or due to the presence of residual bias. Distinguishing among reasons for differences will impact the level of confidence in RWE.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据